Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) PT Lowered to $100 at Oppenheimer

December 17, 2020 7:49 AM
Oppenheimer analyst Hartaj Singh lowered the price target on Gilead Sciences (NASDAQ: GILD) to $100.00 (from $105.00) while maintaining an ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change